The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world clinical outcomes of patients (Pts) with metastatic colorectal cancer (mCRC) who received trifluridine-tipiracil (FTD-TPI) monotherapy or FTD-TPI + bevacizumab (FTD-TPI+bev) combination therapy.
 
Maliha Nusrat
Travel, Accommodations, Expenses - Takeda
(OPTIONAL) Uncompensated Relationships - Haymarket Media
 
Ruizhi Zhao
Employment - Taiho Oncology
 
Nadeem Khan
Employment - Taiho Oncology
 
Yuexi Wang
Employment - ConcertAI
Research Funding - Abbvie (Inst); Amgen (Inst); BeiGene (Inst); Kyowa Kirin International (Inst); Merck (Inst); Taiho Oncology (Inst); Teva (Inst)
 
Dudith Pierre-Victor
Employment - ConcertAI, LLC
 
Jon Tepsick
Employment - ConcertAI
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); EQRx (Inst); Gilead Sciences (Inst); Janssen (Inst); Lilly (Inst); Merck (Inst); Merck KGaA (Inst); Regeneron (Inst); Sandoz (Inst); Taiho Pharmaceutical (Inst); TerSera (Inst)
 
Sharath R
No Relationships to Disclose
 
Christopher Cann
Honoraria - MECC Global Meetings
Consulting or Advisory Role - Curio Science; HMP; Taiho Pharmaceutical; Taiho Pharmaceutical; Targeted Oncology
Travel, Accommodations, Expenses - Association of American Cancer Institutes; PRECISCA
 
Tehseen Salimi
No Relationships to Disclose